N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide

C20H18Cl2N2O3S2 — CID 43838657

IUPACN-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide
SMILESO=C(CCc1ccccc1)/N=C1\SC2CS(=O)(=O)CC2N1c1ccc(Cl)c(Cl)c1
InChIInChI=1S/C20H18Cl2N2O3S2/c21-15-8-7-14(10-16(15)22)24-17-11-29(26,27)12-18(17)28-20(24)23-19(25)9-6-13-4-2-1-3-5-13/h1-5,7-8,10,17-18H,6,9,11-12H2/b23-20-
InChIKeyUFYFXTIRJCDFSN-ATJXCDBQSA-N
MW469.42 g/mol
LogP4.23
Rot. Bonds4

About N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide

N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide (PubChem CID 43838657) has the molecular formula C20H18Cl2N2O3S2 and a molecular weight of 469.42 g/mol. Its IUPAC name is N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide
PubChem CID43838657
Molecular FormulaC20H18Cl2N2O3S2
Molecular Weight469.42 g/mol
Exact Mass468.01
IUPAC NameN-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide
SMILESO=C(CCc1ccccc1)/N=C1\SC2CS(=O)(=O)CC2N1c1ccc(Cl)c(Cl)c1
InChIInChI=1S/C20H18Cl2N2O3S2/c21-15-8-7-14(10-16(15)22)24-17-11-29(26,27)12-18(17)28-20(24)23-19(25)9-6-13-4-2-1-3-5-13/h1-5,7-8,10,17-18H,6,9,11-12H2/b23-20-
InChIKeyUFYFXTIRJCDFSN-ATJXCDBQSA-N
XLogP4.23
TPSA66.81 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500469.42
LogP ≤ 54.23
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide?
The IUPAC name of N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide (CID 43838657) is N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide.
What is the SMILES notation for N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide?
The canonical SMILES for N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide is O=C(CCc1ccccc1)/N=C1\SC2CS(=O)(=O)CC2N1c1ccc(Cl)c(Cl)c1.
What is the InChIKey of N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide?
The InChIKey is UFYFXTIRJCDFSN-ATJXCDBQSA-N. The full InChI is InChI=1S/C20H18Cl2N2O3S2/c21-15-8-7-14(10-16(15)22)24-17-11-29(26,27)12-18(17)28-20(24)23-19(25)9-6-13-4-2-1-3-5-13/h1-5,7-8,10,17-18H,6,9,11-12H2/b23-20-.
What are the key properties of N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide?
N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide has a molecular weight of 469.42 g/mol, XLogP of 4.23, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(3,4-dichlorophenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]-3-phenylpropanamide is sourced from PubChem (CID 43838657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).